CORE--TREATMENT FACILITY
$289,577P30FY2000MHNIH
University Of Pittsburgh At Pittsburgh, Pittsburgh PA
Investigators
Linked publications & trials
Paper 26519639Paper 25066266Paper 23571100Paper 22795206Paper 22687609Paper 18439442Paper 18373384Paper 18272276Paper 18037496Paper 17643912Paper 17276600Paper 16688738Paper 16628130Paper 16337778Paper 16292118Paper 16263851Paper 16135622Paper 15977941Paper 15800159Paper 15782082Paper 15741474Paper 15708300Paper 15648081Paper 15643632Paper 15502595Paper 15381893Paper 15364037Paper 15159090Paper 15157998Paper 15106887Paper 14977459Paper 14572178Paper 14566166Paper 12914894Paper 12906340Paper 12900312Paper 12699032Paper 12649628Paper 12500078Paper 12222086Paper 12218424Paper 12215079Paper 12200555Paper 12091855Paper 12019666Paper 11986509Paper 11815681Paper 11718208Paper 11411181Paper 11321206Paper 11282247Paper 11246080Paper 11121001Paper 11086557Paper 11026174Paper 10965636Paper 10846314Paper 10749950Paper 10714054Paper 10632230
Abstract
A treatment core is proposed with specific aims for infrastructure/quality improvement, scientific development, and training. Specific to the area of scientific development is a series of pilot studies which includes treatment protocols during year 01 for assessment of the pharmacokinetics of the SSRIs and a dose-ranging study of SRRIs in depression. Documentation analytical methods is provided along with data supporting their quality control.
View original record on NIH RePORTER →